CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-22 | Peterson Amy C. CMO, Immuno-oncology | Shares withheld for taxes | −28,185 | $5.39 | $152K | 271,815 |
| 2017-08-11 | BAKER BROS. ADVISORS LP Director | Purchase | +17,777 | $71.00 | $1.3M | 372,975 |
| 2017-08-11 | BAKER BROS. ADVISORS LP Director | Purchase | +158,279 | $71.00 | $11.2M | 3,476,256 |
| 2017-07-12 | Wang Xiaodong Director | Sale | −3,700 | $71.67 | $265K | 16,300 |
| 2017-07-12 | Wang Xiaodong Director | Sale | −15,501 | $72.58 | $1.1M | 799 |
| 2017-07-12 | Wang Xiaodong Director | Sale | −799 | $73.22 | $58K | 0 |
| 2017-07-11 | Glazer Donald W. Director | Gift | −175,682 | 4,565,794 | ||
| 2017-07-10 | Glazer Donald W. Director | Sale | −3,604 | $71.71 | $258K | 7,206 |
| 2017-07-10 | Glazer Donald W. Director | Sale | −7,206 | $72.36 | $521K | 0 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −7,345 | $60.62 | $445K | 212,055 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −6,901 | $61.50 | $424K | 205,154 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −10,324 | $62.57 | $646K | 194,830 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −30,390 | $63.63 | $1.9M | 164,440 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −44,695 | $64.51 | $2.9M | 119,745 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −64,553 | $65.42 | $4.2M | 55,192 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −51,821 | $66.35 | $3.4M | 3,371 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −3,071 | $67.36 | $207K | 300 |
| 2017-07-06 | OYLER JOHN Chief Executive Officer | Sale | −300 | $68.11 | $20K | 0 |
| 2017-06-29 | Liang Howard CFO & CSO | Grant or award · Share Option (Right to Buy) | +1,250,000 | 1,250,000 | ||
| 2017-06-29 | Liang Howard CFO & CSO | Grant or award · Share Option (Right to Buy) | +1,250,000 | 1,250,000 |
Page 117 of 123 · 2,455 trades